Helix Selects DNA Genotek's Oragene® Collection Device And GenoFIND Fulfillment Services For Genetic Discovery Applications

- Oragene ® ¿Dx  saliva collection kits to provide reliable DNA samples for Helix -

BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that Helix, the personal genomics company, has selected the Oragene ® ¿ ¿Dx device to provide reliable self-collection of DNA samples to be used in a genetic information discovery service offered by Helix for consumers.  OraSure's wholly-owned subsidiary, DNA Genotek, will supply the Oragene ® ¿ ¿Dx device and will also provide kit fulfillment and logistics services for Helix through its GenoFIND offering.

Helix provides a secure and affordable means for consumers to access data and information about their DNA, through uniquely personalized applications created by Helix partners. The Oragene ® ¿ ¿Dx collector will be used to collect saliva samples from consumers and those samples will be sequenced in Helix's lab. Customers will then be able to access DNA-powered insights in products and experiences created by Helix partners—including well-known clinical and consumer brands—in the areas of health, fitness, genealogy, family planning, lifestyle, and nutrition.

"Reliable and easy-to-use sample collection is a key part of our offering. The ability to collect a high quality DNA sample for next generation sequencing is critical to ensuring accurate results for our customers," said Dr. James Lu, Co-founder & Senior Vice President of Applied Genomics at Helix. "DNA Genotek is a leader in its field, and we are excited to work with them to bring customers an efficient experience right from the start."

If you liked this article you might like

Stocks Under $10 Portfolio: Not Resting on Our Laurels

How to Cash in on the Fight Against the Zika Virus

OraSure (OSUR) Stock Spikes, Upgraded at Stephens

4 Stocks for Fighting Zika

OraSure Technologies (OSUR) Stock Jumps on Zika Test Contract